Trials / Completed
CompletedNCT01748864
Evaluation of the Biodistribution and Safety of 99mTC-Etarfolatide (EC20) in Normal Volunteers
A Single-Center Phase I Clinical Study to Evaluate The Biodistribution and Safety of 99mTC-Etarfolatide (EC20) in Normal Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 23 (actual)
- Sponsor
- Endocyte · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
A Phase 1, single-center, open-label, single arm, baseline-controlled (for safety) study in normal volunteers. Study will determine biodistribution and excretion of the radioactive drug substance and evaluate the safety and tolerability of 99mTC-Etarfolatide in normal volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Etarfolatide (EC20) |
Timeline
- Start date
- 2013-04-01
- Primary completion
- 2013-10-01
- Completion
- 2013-10-01
- First posted
- 2012-12-13
- Last updated
- 2014-07-29
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01748864. Inclusion in this directory is not an endorsement.